Literature DB >> 16223723

SLAM-associated protein as a potential negative regulator in Trk signaling.

Kin Yip Lo1, Wing Hong Chin, Yu Pong Ng, Albert W Cheng, Zelda H Cheung, Nancy Y Ip.   

Abstract

Neurotrophin signaling plays important roles in regulating the survival, differentiation, and maintenance of neurons in the nervous system. Binding of neurotrophins to their cognate receptors Trks induces transactivation and phosphorylation of the receptor at several tyrosine residues. These phosphorylated tyrosine residues then serve as crucial docking sites for adaptor proteins containing a Src homology 2 or phosphotyrosine binding domain, which upon association with the receptor initiates multiple signaling events to mediate the action of neurotrophins. Here we report the identification of a Src homology 2 domain-containing molecule, SLAM-associated protein (SAP), as an interacting protein of TrkB in a yeast two-hybrid screen. SAP was initially identified as an adaptor molecule in SLAM family receptor signaling for regulating interferon-gamma secretion. In the current study, we found that SAP interacted with TrkA, TrkB, and TrkC receptors in vitro and in vivo. Binding of SAP required Trk receptor activation and phosphorylation at the tyrosine 674 residue, which is located in the activation loop of the kinase domain. Overexpression of SAP with Trk attenuated tyrosine phosphorylation of the receptors and reduced the binding of SH2B and Shc to TrkB. Moreover, overexpression of SAP in PC12 cells suppressed the nerve growth factor-dependent activation of extracellular signal-regulated kinases 1/2 and phospholipase Cgamma, in addition to inhibiting neurite outgrowth. In summary, our findings demonstrated that SAP may serve as a negative regulator of Trk receptor activation and downstream signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16223723     DOI: 10.1074/jbc.M506554200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  α2-chimaerin controls neuronal migration and functioning of the cerebral cortex through CRMP-2.

Authors:  Jacque P K Ip; Lei Shi; Yu Chen; Yasuhiro Itoh; Wing-Yu Fu; Andrea Betz; Wing-Ho Yung; Yukiko Gotoh; Amy K Y Fu; Nancy Y Ip
Journal:  Nat Neurosci       Date:  2011-12-04       Impact factor: 24.884

Review 2.  Neurotrophic fragments as therapeutic alternatives to ameliorate brain aging.

Authors:  Itzel Ortiz Flores; Samuel Treviño; Alfonso Díaz
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

3.  Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Biomark Insights       Date:  2007-02-14

Review 4.  Are Viral Infections Key Inducers of Autoimmune Diseases? Focus on Epstein-Barr Virus.

Authors:  Masami Takei; Noboru Kitamura; Yosuke Nagasawa; Hiroshi Tsuzuki; Mitsuhiro Iwata; Yasuko Nagatsuka; Hideki Nakamura; Kenichi Imai; Shigeyoshi Fujiwara
Journal:  Viruses       Date:  2022-08-27       Impact factor: 5.818

5.  Cdk5 is involved in BDNF-stimulated dendritic growth in hippocampal neurons.

Authors:  Zelda H Cheung; Wing Hong Chin; Yu Chen; Yu Pong Ng; Nancy Y Ip
Journal:  PLoS Biol       Date:  2007-04       Impact factor: 8.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.